{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:59:41Z","timestamp":1774421981242,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004091","name":"Kumamoto University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004091","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004420","name":"Wakayama Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004420","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.gene.2021.145421","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T15:05:56Z","timestamp":1610550356000},"page":"145421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines"],"prefix":"10.1016","volume":"774","author":[{"given":"Hiroki","family":"Hosoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Niibori-Nambu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giselle Sek Suan","family":"Nah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avinash Govind","family":"Bahirvani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle Meng Huang","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaomi","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan Prem","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel G.","family":"Tenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sonoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motomi","family":"Osato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2021.145421_b0005","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0042-6822(91)90893-G","article-title":"Early events in Epstein-Barr virus infection of human B lymphocytes","volume":"181","author":"Alfieri","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.gene.2021.145421_b0010","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.celrep.2017.05.082","article-title":"The super-enhancer-derived alncRNA-EC7\/bloodlinc potentiates red blood cell development in trans","volume":"19","author":"Alvarez-Dominguez","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2021.145421_b0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.celrep.2014.06.046","article-title":"Disruption of Runx1 and Runx3 leads to bone marrow failure and leukemia predisposition due to transcriptional and DNA repair defects","volume":"8","author":"Wang","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2021.145421_b0020","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1073\/pnas.86.23.9558","article-title":"Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation","volume":"86","author":"Cohen","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.gene.2021.145421_b0025","doi-asserted-by":"crossref","first-page":"14592","DOI":"10.1073\/pnas.1200037109","article-title":"Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFbeta interaction","volume":"109","author":"Cunningham","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.gene.2021.145421_b0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/leu.2013.338","article-title":"Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia","volume":"28","author":"Dawson","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.gene.2021.145421_b0035","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.1073\/pnas.91.16.7568","article-title":"The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein","volume":"91","author":"Grossman","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.gene.2021.145421_b0040","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1093\/nar\/gkw085","article-title":"RUNX super-enhancer control through the Notch pathway by Epstein-Barr virus transcription factors regulates B cell growth","volume":"44","author":"Gunnell","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2021.145421_b0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1126\/science.8016657","article-title":"Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa","volume":"265","author":"Henkel","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.gene.2021.145421_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ebiom.2016.04.032","article-title":"Small molecule inhibitor of CBFbeta-RUNX binding for RUNX transcription factor driven cancers","volume":"8","author":"Illendula","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.gene.2021.145421_b0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrc3877","article-title":"The RUNX family: developmental regulators in cancer","volume":"15","author":"Ito","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"561\u2013573","key":"10.1016\/j.gene.2021.145421_b0060","article-title":"The epstein-barr virus regulome in lymphoblastoid cells","volume":"22","author":"Jiang","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.gene.2021.145421_b0065","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/JVI.73.5.4481-4484.1999","article-title":"The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2","volume":"73","author":"Kaiser","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2021.145421_b0070","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1038\/s41467-019-09710-z","article-title":"Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm","volume":"10","author":"Kubota","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2021.145421_b0075","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nature13393","article-title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","volume":"511","author":"Kwiatkowski","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.gene.2021.145421_b0080","doi-asserted-by":"crossref","first-page":"14121","DOI":"10.1073\/pnas.1616697113","article-title":"Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation","volume":"113","author":"Liang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.gene.2021.145421_b0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Loven","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.gene.2021.145421_b0090","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1126\/science.1259037","article-title":"Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element","volume":"346","author":"Mansour","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.gene.2021.145421_b0095","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.1108190108","article-title":"Targeting MYC dependence in cancer by inhibiting BET bromodomains","volume":"108","author":"Mertz","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.gene.2021.145421_b0100","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1172\/JCI91788","article-title":"Genetic regulation of the RUNX transcription factor family has antitumor effects","volume":"127","author":"Morita","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2021.145421_b0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-981-10-3233-2_16","article-title":"The RUNX genes as conditional oncogenes: insights from retroviral targeting and mouse models","volume":"962","author":"Neil","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.gene.2021.145421_b0110","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ng.3167","article-title":"What are super-enhancers?","volume":"47","author":"Pott","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2021.145421_b0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2012.06.007","article-title":"Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia","volume":"22","author":"Sanda","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2021.145421_b0120","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1038\/leu.2017.40","article-title":"RUNX3 is oncogenic in natural killer\/T-cell lymphoma and is transcriptionally regulated by MYC","volume":"31","author":"Selvarajan","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.gene.2021.145421_b0125","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1128\/JVI.76.10.4919-4927.2002","article-title":"Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype","volume":"76","author":"Spender","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2021.145421_b0130","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1038\/sj.onc.1208404","article-title":"Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells","volume":"24","author":"Spender","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2021.145421_b0135","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/blood.2018874503","article-title":"The enhancer RNA ARIEL activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia","volume":"134","author":"Tan","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.gene.2021.145421_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005892","article-title":"RUNX3 has an oncogenic role in head and neck cancer","volume":"4","author":"Tsunematsu","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gene.2021.145421_b0145","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.cell.2015.04.048","article-title":"RUNX3 controls a metastatic switch in pancreatic ductal adenocarcinoma","volume":"161","author":"Whittle","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.gene.2021.145421_b0150","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1158\/0008-5472.CAN-19-3167","article-title":"Overexpression of RUNX3 represses RUNX1 to drive transformation of myelodysplastic syndrome","volume":"80","author":"Yokomizo-Nakano","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2021.145421_b0155","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nature05473","article-title":"Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2","volume":"445","author":"Young","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.gene.2021.145421_b0160","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nrc.2016.92","article-title":"Epstein-barr virus: more than 50 years old and still providing surprises","volume":"16","author":"Young","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.gene.2021.145421_b0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.chom.2014.12.013","article-title":"Epstein-Barr virus oncoprotein super-enhancers control B cell growth","volume":"17","author":"Zhou","year":"2015","journal-title":"Cell Host Microbe"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111921000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111921000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:39:04Z","timestamp":1759855144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111921000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":33,"alternative-id":["S0378111921000159"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2021.145421","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2021.145421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"145421"}}